Related Experiment Videos
Molecular basis for the high affinity interaction between the thymic leukemia antigen and the CD8alphaalpha molecule
Antoine Attinger1, Lesley Devine, Yiran Wang-Zhu
1La Jolla Institute for Allergy and Immunology, San Diego, CA 92121, USA.
Journal of Immunology (Baltimore, Md. : 1950)
|March 8, 2005
Summary
The thymic leukemia (TL) antigen binds strongly to CD8alphaalpha due to three key amino acids. These changes in MHC class I molecules can significantly impact lymphocyte regulation.
Area of Science:
- Immunology
- Molecular Biology
- Cellular Biology
Background:
- The thymic leukemia (TL) antigen is a nonclassical MHC class I molecule.
- TL antigen exhibits higher affinity for CD8alphaalpha than CD8alphabeta.
- CD8alphaalpha-TL interaction is crucial for intestinal lymphocyte regulation.
Purpose of the Study:
- To investigate the molecular basis of TL antigen binding to CD8alphaalpha.
- To understand how specific amino acids contribute to the high-affinity interaction.
Main Methods:
- Site-directed mutagenesis of classical class I molecules.
- Analysis of binding affinity between modified class I molecules and CD8alphaalpha.
- Assessment of lymphocyte function modulation.
Main Results:
- Three amino acids in the alpha3 domain of TL antigen are primarily responsible for the enhanced binding to CD8alphaalpha.
- Mutant classical class I molecules with TL antigen amino acid substitutions acquired CD8alphaalpha binding capabilities.
- These molecular alterations influenced lymphocyte function.
Conclusions:
- Specific amino acid substitutions in the alpha3 domain of MHC class I molecules can dictate CD8alphaalpha binding.
- Minor alterations in MHC class I structure can lead to significant physiological consequences in lymphocyte regulation.